LabCorp
LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
Alert:
LabCorp COVID-19 Antibody Testing Available Nationwide Learn more >>>
Test Includes
Methylenedioxyamphetamine (MDA); methylenedioxyethylamphetamine (MDEA); methylenedioxymethamphetamine (MDMA)
|
|
|
Methylenedioxyamphetamine (MDA); methylenedioxyethylamphetamine (MDEA); methylenedioxymethamphetamine (MDMA) |
Special Instructions
Chain-of-custody documentation is required for samples submitted for preëmployment testing, random employee testing, and forensic purposes. For other applications, use the standard request form. Please mark chain-of-custody test number on the request form.
Expected Turnaround Time
3 - 5 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Specimen Requirements
Specimen
Urine
Volume
20 mL
Container
Use plastic urine drug bottle and tamper-evident seal for forensic specimen. Collection kits are available by request from the laboratory.
Collection
Urine temperature monitoring is recommended for samples to be tested for medicolegal purposes.
Storage Instructions
Maintain specimen at room temperature. If arrival extends beyond seven days, then refrigerate.
Causes for Rejection
Quantity not sufficient for analysis; improper specimen (serum, plasma, blood); incomplete chain-of-custody documentation; incomplete specimen identification; improper or missing tamper-evident seals
Test Details
Use
Drugs of abuse testing
Methodology
Mass spectrometry (MS)
LOINC® Map
| Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
|---|---|---|---|---|---|---|
| 071318 | MDMA Confirmation, Urine | 071307 | MDMA + Metabolites | 73971-4 | ||
| 071318 | MDMA Confirmation, Urine | 071310 | MDA | 42253-5 | ||
| 071318 | MDMA Confirmation, Urine | 071311 | MDA GC/MS Conf | ng/mL | 20545-0 | |
| 071318 | MDMA Confirmation, Urine | 071312 | MDMA | 14267-9 | ||
| 071318 | MDMA Confirmation, Urine | 071313 | MDMA GC/MS Conf | ng/mL | 18358-2 | |
| 071318 | MDMA Confirmation, Urine | 071314 | MDEA | 61048-5 | ||
| 071318 | MDMA Confirmation, Urine | 071315 | MDEA GC/MS Conf | ng/mL | 45143-5 |
© 2020 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf